<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Consolas;
panose-1:2 11 6 9 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:black;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:black;}
pre
{mso-style-priority:99;
mso-style-link:"HTML Preformatted Char";
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Courier New";
color:black;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";
color:black;}
span.HTMLPreformattedChar
{mso-style-name:"HTML Preformatted Char";
mso-style-priority:99;
mso-style-link:"HTML Preformatted";
font-family:Consolas;
color:black;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";
color:black;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body bgcolor="white" lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">I assume by “toxicity” you mean “dilution”? Because dilution of the good-stuff (in this case, 67Cu) is usually the limiting factor toward utility. I should
start by saying that the answer that I got from City of Hope Hospital researchers in California may depend greatly on the kind of research one is doing. For some of their research they wanted Specific Activity (SA) of approximately 20 Ci/g, while for other
tissue-culture research they could live with an SA of 1 Ci/g. These correspond to very roughly 1 67Cu atom per 10,000 – 100,000 other Cu atoms.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">That sounds like a lot of stable Cu atoms. Except EVERYTHING has Cu in it: your skin, the air, plastics, glassware, purified and enriched Ga targets, purified
and Zn targets, water, everything. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">And therein lies the challenge. For people have known how to make 67Cu for a long time, and BNL has invested a considerable sum producing it, only to find
that the final product was inconsistent in purity/SA quality and, therefore, unusable for large-scale research trials.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">D<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:windowtext">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:windowtext"> Isotope-prod [mailto:isotope-prod-bounces@jlab.org]
<b>On Behalf Of </b>Pavel Degtiarenko<br>
<b>Sent:</b> Monday, September 28, 2015 4:29 PM<br>
<b>To:</b> isotope-prod@jlab.org<br>
<b>Subject:</b> Re: [Isotope-prod] Reminder VCU Talk Monday 11:30 CC F224-5<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal">Dear All, <br>
<br>
Could anyone clarify to us the situation with the toxicity of Copper: what ratio of (Cu-63 + Cu-65) to Cu-67 atoms in the final product is too big, such that the product would become unacceptable.<br>
<br>
We understand now that by making Cu-67 from Gallium, for example, the ratio could be done less than an order of few times, or even less than one. In case of Zinc target the ratio would be worse because the stable isotopes of Zinc are closer in both Z and A
to stable Cu-63 and Cu-65 than the isotopes of Gallium. I guess this ratio would be enormous if Cu-67 is produced in Copper with double neutron captures on reactors.<br>
<br>
In our conditions, without the initial Copper in the target, the ratio should stay rather limited, with the Gallium target having some advantage in that respect. Would that be good enough? What would be a hard limit on the ratio?<br>
<br>
Best regards,<br>
Pavel<br>
<br>
<br>
<br>
On 9/28/2015 5:12 PM, Sundaresan Gobalakrishnan wrote:<o:p></o:p></p>
</div>
<blockquote style="margin-top:5.0pt;margin-bottom:5.0pt">
<p>Actinium-225 and Copper-67 are the first two products that we could initially try, due to their high medical relevance and in-house availability of related technologies for in vivo delivery in living subjects (in mice for now).<o:p></o:p></p>
<p>Best regards,<br>
Sundaresan<o:p></o:p></p>
<div>
<p class="MsoNormal">On Sep 28, 2015 4:46 PM, "Wells, Douglas P." <a href="mailto:Doug.Wells@sdsmt.edu">
<Doug.Wells@sdsmt.edu></a> wrote:<o:p></o:p></p>
<div>
<div>
<p class="MsoNormal">I wonder if, in the meantime - before the phone call is held, VCU can share with us the list of nuclear species that they are interested in? We (SDSM&T) could look into photo-production of them if we knew what species are on their mind.<br>
<br>
Thanks---D<br>
<br>
-----Original Message-----<br>
From: Isotope-prod [<a href="mailto:isotope-prod-bounces@jlab.org">mailto:isotope-prod-bounces@jlab.org</a>] On Behalf Of Sundaresan Gobalakrishnan<br>
Sent: Monday, September 28, 2015 7:38 AM<br>
To: George Neil; isotope production<br>
Subject: Re: [Isotope-prod] Reminder VCU Talk Monday 11:30 CC F224-5<br>
<br>
Dear George and All,<br>
<br>
I regret to inform you that due to an emergency in Dr. Zweit's family, he will not be able to come and present his ideas at JLab today.
<br>
<br>
Once he returns to work, he will get in touch with you to reschedule his presentation.<br>
<br>
Very sorry about any inconvenience this may cause.<br>
<br>
Best regards,<br>
Sundaresan<br>
<br>
_____________________________________________<br>
Sundaresan Gobalakrishnan, PhD<br>
Assistant Professor<br>
Center for Molecular Imaging, Department of Radiology Virginia Commonwealth University, Richmond, VA - 23298<br>
Phone: 804-628-9165; Fax: 804-628-0223<br>
E-mail: <a href="mailto:sundaresan.gobalakrishnan@vcuhealth.org">sundaresan.gobalakrishnan@vcuhealth.org</a><br>
<br>
<br>
<br>
-----Original Message-----<br>
From: Isotope-prod [<a href="mailto:isotope-prod-bounces@jlab.org">mailto:isotope-prod-bounces@jlab.org</a>] On Behalf Of George Neil<br>
Sent: Friday, September 25, 2015 11:39 AM<br>
To: isotope production <a href="mailto:isotope-prod@jlab.org"><isotope-prod@jlab.org></a><br>
Subject: [Isotope-prod] Reminder VCU Talk Monday 11:30 CC F224-5<br>
<br>
<br>
_______________________________________________<br>
Isotope-prod mailing list<br>
<a href="mailto:Isotope-prod@jlab.org">Isotope-prod@jlab.org</a><br>
<a href="https://mailman.jlab.org/mailman/listinfo/isotope-prod">https://mailman.jlab.org/mailman/listinfo/isotope-prod</a><br>
<br>
<br>
_______________________________________________<br>
Isotope-prod mailing list<br>
<a href="mailto:Isotope-prod@jlab.org">Isotope-prod@jlab.org</a><br>
<a href="https://mailman.jlab.org/mailman/listinfo/isotope-prod">https://mailman.jlab.org/mailman/listinfo/isotope-prod</a><o:p></o:p></p>
</div>
</div>
</div>
<p class="MsoNormal"><br>
<br>
<br>
<o:p></o:p></p>
<pre>_______________________________________________<o:p></o:p></pre>
<pre>Isotope-prod mailing list<o:p></o:p></pre>
<pre><a href="mailto:Isotope-prod@jlab.org">Isotope-prod@jlab.org</a><o:p></o:p></pre>
<pre><a href="https://mailman.jlab.org/mailman/listinfo/isotope-prod">https://mailman.jlab.org/mailman/listinfo/isotope-prod</a><o:p></o:p></pre>
</blockquote>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>